Medical Devices Series C Investors & VC Firms
439 firms in this list, with a median first check of $1M. 92 of them lead rounds. Generated from verified public data and updated continuously.
Aravis Ventures
ZurichSeed–Late Stage
4 people
Abbhi Capital
MiamiPre-Seed–Late Stage
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
Hotung Investment Holdings Ltd.
SingaporeSeries A–Late Stage$300K – $1.5M
JAFCO Group
TokyoPre-Seed–Late Stage$1.9M – $198M
Navivo Capital
WarsawSeries A–Late Stage
3 people
Red Capital
TokyoPre-Seed–Growth
3 people
Aurum Ventures MKI
Ramat GanSeed–Late Stage
8 people
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $76M
Northwell Holdings
New YorkSeed–Late Stage
1 person
Innovation Engine
TokyoPre-Seed–Late Stage
3 people
Nissay Capital
TokyoPre-Seed–Late Stage$610K – $71M
1 person
MB Venture Partners
MemphisPre-Seed–Late Stage
2 people
Strategic Investment Partners Inc.
TokyoPre-Seed–Growth
2 people
venture / science
San Francisco Bay AreaSeed–Late Stage
2 people
KSP, Inc.
KawasakiPre-Seed–Growth
1 person
NJF Capital
LondonSeed–Late Stage
1 person
Reverent Partners
SeoulSeries A–Late Stage
Lundbeckfonden Ventures
CopenhagenPre-Seed–Late Stage
1 person
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Stonebridge Ventures
SeoulSeed–Late Stage$743K – $33M
3 people
TriWise Capital
ShenzhenPre-Seed–Late Stage
1 person
MedVenture Partners, Inc.
TokyoPre-Seed–Growth
7 people
Related lists
Series C Investors & VC Firms (2842)Medical Devices Investors & VC Firms (1451)Series C Investors & VC Firms in North America (1414)Series C Investors & VC Firms in United States (1223)Medical Devices Seed Investors & VC Firms (1203)Medical Devices Series A Investors & VC Firms (1188)Series C Investors & VC Firms in Asia-Pacific (994)Series C Investors & VC Firms in Europe (960)Medical Devices Investors & VC Firms in North America (945)Series C Investors & VC Firms in Global (936)
Data sourced from public filings and firms' own websites — see our methodology.

















